EU Commission fines pharma companies for price fixing

  • 📰 SaltWire Network
  • ⏱ Reading Time:
  • 14 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 9%
  • Publisher: 63%

Business News News

Business Business Latest News,Business Business Headlines

Explore stories from Atlantic Canada.

BRUSSELS - The European Commission on Thursday said it had fined five pharmaceutical companies for a total of 13.4 million euros in a settlement of an antitrust investigation.

The commission fined Alkaloids of Australia, Alkaloids Corporation, Boehringer, Linnea and Transo-Pharm for participating in a cartel aimed at fixing the minimum price of an ingredient to produce the abdominal antispasmodic drug Buscopan and its generic versions.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 45. in BUSİNESS

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

U.S. Treasury bond ETFs draw net inflows this year despite recent market routExplore stories from Atlantic Canada.
Source: SaltWire Network - 🏆 45. / 63 Read more »

Planemakers bet on steady demand for business jets, but Wall Street waryExplore stories from Atlantic Canada.
Source: SaltWire Network - 🏆 45. / 63 Read more »

EU securities watchdog warns investors over crypto market protectionsExplore stories from Atlantic Canada.
Source: SaltWire Network - 🏆 45. / 63 Read more »